Cypress Pharmaceutical rolls out new generic drug


Published: May 2,2011

Tags: drugs, manufacturing, medicine

MADISON — Cypress Pharmaceutical Inc. has commercially launched Epinastine HCl Ophthalmic Solution, 0.05%, which is AT-rated to Allergan’s ELESTAT (epinastine HCl ophthalmic solution) 0.05%.

As the first company to file an abbreviated new drug application (ANDA) containing a paragraph IV certification for this product, Cypress has been awarded a 180-day period of marketing exclusivity.

Cypress, founded in 1993, is a specialty pharmaceutical company that develops, markets and distributes generic prescription pharmaceutical products to leading national pharmaceutical wholesalers, chain drug stores, distributors and other retail merchandisers.

Source: Cypress Pharmaceutical Inc.

[RSS Feed] []

To sign up for Mississippi Business Daily Updates, click here.



Top Posts & Pages